Risk modifiers and mortality in patients with high platelet reactivity to Adenosine-diphosphate (ADP) in the LURIC study

Back

ESC Premium Access

Risk modifiers and mortality in patients with high platelet reactivity to Adenosine-diphosphate (ADP) in the LURIC study

Session: Atrial Fibrillation, Platelet Aggregation and Outcomes

Topic: Biomarkers

Speaker: Doctor M. Berger (Aachen, DE)

Event: ESC Congress 2020

Congress Presentation

Add to my library

About the speaker

Doctor Martin Berger

RWTH University Hospital Aachen, Aachen (Germany)

0 follower

6 more presentations in this session

Impact of body mass index on outcomes in european patients with atrial fibrillation: the ESC EHRA EORP Atrial Fibrillation General Long-Term Registry (AFGen LT)

Speaker: Professor G. Boriani (Modena, IT)

Access

Abstract

Slides

Atrial fibrillation risk factor burden and disease onset across age decades.

Speaker: Associate Professor B. Morseth (Tromso, NO)

Access

Abstract

Slides

Clinical phenotypes of atrial fibrillation and risk of mortality: a cluster analysis.

Speaker: Assistant Professor D. Pastori (Rome, IT)

Access

Abstract

Slides

Long term antithrombotic treatment in atrial fibrillation patients undergoing coronary surgery.

Speaker: Doctor M. Skibniewski (Linkoping, SE)

Access

Abstract

Slides

Thromboxane metabolite excretion is associated with serious vascular events in diabetes mellitus: a sub-study of the ASCEND trial

Speaker: Associate Professor B. Rocca (Casamassima, IT)

Access

Abstract

Slides

Access the full session

Atrial Fibrillation, Platelet Aggregation and Outcomes

Speakers: Doctor M. Berger, Professor G. Boriani, Associate Professor B. Morseth, Assistant Professor D. Pastori, Doctor M. Skibniewski...

Access

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources